Lymph node ratio as an indicator of nodal status in the assessment of survival and recurrence in vulvar cancer: A cohort study
Open Access
- 1 January 2024
- journal article
- research article
- Published by SAGE Publications in Women's Health
- Vol. 20
Abstract
Background: Inguinal lymph node (LN) metastasis and particularly the number of metastatic lymph nodes (NMLN) represent a determinant prognostic factor in vulvar squamous cell carcinoma (VSCC). However, the NMLN may be related to the number of removed LNs. Therefore, the lymph node ratio (LNR) reflects not only the burden of LN involvement but also the quality and extent of lymphadenectomy. Objectives: To investigate the value of the LNR and the count of LN on overall survival (OS) and recurrence-free survival (RFS). Design: This study is a retrospective, longitudinal, institution-based study. Methods: This study included 192 patients treated for VSCC at the Salah Azaiez Institute between 1994 and 2022. Clinical, pathological, and evolutionary data were reported. Survival curves were generated by the Kaplan–Meier method, and predictive factors of outcome were analyzed using Cox proportional hazards models. Results: Surgery consisted of a radical vulvectomy, hemivulvectomy, and pelvic exenteration in, respectively, 96.4%, 2.1%, and 1.6% of cases followed by adjuvant radiotherapy in 38.5% of cases. LN dissection was bilateral in 88.5% of cases. LNR = 0, LNR = 0–0.2, and LNR ⩾0.2 were recorded in, respectively, 64.7%, 22.1%, and 13.2% of cases. With a mean follow-up time of 35 ± 42.06 months, the 5-year OS was 52.5% and the 5-year RFS was 55.8%. On multivariate analysis, the independent prognostic factors of OS were the LNR (hazard ratio (HR) = 5.702; 95% confidence interval (CI) = 2.282–14.245; p < 0.0001), Federation of Gynecology and Obstetrics (FIGO) stage (HR = 2.089; 95% CI = 1.028–4.277; p = 0.042), and free margins (HR = 2.247; 95% CI = 1.215–4.155; p = 0.01). Recurrences were recorded in 37.5% of cases. Independent prognostic factors of RFS were the LNR (HR = 2.911; 95% CI = 1.468–5.779; p = 0.002), FIGO stage (HR = 1.835; 95% CI = 1.071–3.141; p = 0.027), and free margins (HR = 2.091; 95% CI = 1.286–3.999; p = 0.003). Conclusion: Surgical margin, FIGO stage, and LNR represent the independent prognostic factors of survival and LNR showed superior prognostic predictive accuracy compared with the revised 2021 FIGO staging system for predicting OS and RFS in VSCC.Keywords
This publication has 26 references indexed in Scilit:
- The prognostic role of FIGO stage in patients with vulvar cancer: a systematic review and meta-analysisCurrent Medical Research and Opinion, 2016
- Prognostic role of inguinal lymphadenectomy in vulvar squamous carcinoma: younger and older patients should be equally treated. A prospective study and literature reviewGynecologic Oncology, 2015
- Prognostic value of the number and laterality of metastatic inguinal lymph nodes in vulvar cancer: Revisiting the FIGO staging systemEuropean Journal of Surgical Oncology, 2013
- Does the count after inguinofemoral lymphadenectomy in vulvar cancer correlate with outcome?European Journal of Surgical Oncology, 2013
- Impact of the new FIGO 2009 staging classification for vulvar cancer on prognosis and stage distributionGynecologic Oncology, 2012
- Prognostic Role of Lymph Node Metastases in Vulvar Cancer and Implications for Adjuvant TreatmentInternational Journal of Gynecological Cancer, 2012
- Prognostic value of lymph node status and number of removed nodes in patients with squamous cell carcinoma of the vulva treated with modified radical vulvectomy and inguinal-femoral lymphadenectomy.2012
- Does the number of nodes removed impact survival in vulvar cancer patients with node-negative disease?Gynecologic Oncology, 2010
- Radiation Therapy Compared With Pelvic Node Resection for Node-Positive Vulvar CancerObstetrics & Gynecology, 2009
- Node count and groin recurrence in early vulvar cancer: A Gynecologic Oncology Group studyGynecologic Oncology, 2009